Management and strategy consulting for life science companies
Follow MD Becker Partners
Quoted in the news…
5/7/2012 – “Insight: Training immune system to fight cancer comes of age” by Bill Berkrot of Reuters
3/2/2012 – “Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex’s Crash” by Adam Feuerstein of TheStreet.com
2/27/2012 – “Dendreon Shares Drop on Slowing Sales of Cancer Vaccine Provenge” by Brett Chase of Minyanville
1/26/2012 – “Amgen, Celgene, Roche Deals Signal M&A Frenzy for Drug Companies” by Brett Chase of Minyanville
1/5/2012 – “Dendreon reports spike in Provenge sales; shares soar” by Bill Berkrot of Reuters
10/11/2011 – “Nobel prize-winning science should incubate deals” by David Holley of The Deal
10/7/2011 – “Zytiga creeps up on Provenge prostate-cancer drug” by Ransdell Pierson of Reuters
8/23/2011 – “What’s a Cancer Drug Worth?” by Brett Chase of Minyanville
8/22/2011 – “With Dendreon Humbled, Lessons Learned For Cancer Vaccine Makers” by Emily Hayes of The Pink Sheet
Press Releases & Events
October 4, 2012 – MD Becker Partners will be hosting its 3rd annual “Cancer Immunotherapy: A Long Awaited Reality” conference event in New York. For more information, please Click Here for the Event Website.
April 12, 2012 – “MD Becker Partners Releases White Paper: 2012 – A Pivotal Year for Alzheimer’s Disease Drug Development” press release
March 11-14, 2012 – MD Becker Partners sponsored ROTH Capital Partners’ 24th Annual Growth Stock Conference in Dana Point, California. Michael Becker also moderated a fireside chat with industry experts titled “Identifying Strategic Value: M&A and Public Market Trends.”
November 10, 2011 – “MD Becker Partners Celebrates Third Successful Year in Business” press release
October 6, 2011 – MD Becker Partners hosted its 2nd annual “Cancer Immunotherapy: A Long Awaited Reality” conference event in New York. For more information, please Click Here for the Event Website and for select video replays, visit the firm’s YouTube channel by clicking here.
June 30, 2011 – “Expert Roundtable Explores Recent Advances in Cancer Immunotherapy; Cancer Research Institute and MD Becker Partners Jointly Publish New Industry Report” press release
Relations | Strategy | Operations
MD Becker Partners LLC
1099 General Knox Road, Suite 1B
Washington Crossing, PA 18977
Toll-free: 855-MDB-PART | Direct: 215-710-8710
Legal Disclaimer | © 2012MD Becker Partners LLC • Built on the Genesis Framework